![Sheila Ranganath](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sheila Ranganath
Private Equity Investor bei
Flagship Pioneering, Inc.
Profil
Sheila Ranganath is Senior Vice President at Flagship Pioneering, Inc. since 2024.
Formerly, Dr. Ranganath was Vice President- Biology at LifeMine Therapeutics, Inc. from 2021 to 2022, Director at Merck & Co., Inc. from 2019 to 2021, Director at Enumeral Biomedical Holdings, Inc. in 2016, and Principal at Pfizer Inc. in 2011.
Education includes a doctorate from the University of Washington and an undergraduate degree from the University of California.
Aktive Positionen von Sheila Ranganath
| Unternehmen | Position | Beginn |
|---|---|---|
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 01.04.2022 |
Ehemalige bekannte Positionen von Sheila Ranganath
| Unternehmen | Position | Ende |
|---|---|---|
LifeMine Therapeutics, Inc.
 LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs from fungi which aims to cure untreatable and significant chronic diseases | Private Equity Investor | 02.03.2022 |
| MERCK & CO., INC. | Private Equity Investor | 02.04.2021 |
| ENUMERAL BIOMEDICAL HOLDINGS INC | Private Equity Investor | 02.08.2016 |
| PFIZER INC. | Corporate Officer/Principal | 02.04.2011 |
Ausbildung von Sheila Ranganath
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
47
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Enumeral Biomedical Holdings, Inc.
 Enumeral Biomedical Holdings, Inc. BiotechnologyHealth Technology Develops novel antibody immunotherapies designed to help immune system attack diseased cells | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LifeMine Therapeutics, Inc.
LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs from fungi which aims to cure untreatable and significant chronic diseases | Health Technology |
